Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
JOURNAL OF MEDICINAL CHEMISTRY
Journal
Overview
Research
Identifiers
Other
View All
Overview
publication venue for
Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function
. 65:15391-15415.
2022
Development of a Redox-Sensitive Spermine Prodrug for the Potential Treatment of Snyder Robinson Syndrome
. 64:15593-15607.
2021
Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist
. 64:14860-14875.
2021
Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer's Disease
. 64:10934-10950.
2021
Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput "Unbiased" Screening Campaign
. 64:5577-5592.
2021
LMP2 Inhibitors as a Potential Treatment for Alzheimer's Disease
. 63:3763-3783.
2020
Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation
. 63:1724-1749.
2020
Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib
. 62:4444-4455.
2019
Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μm MC4R Partial Agonist
. 62:2738-2749.
2019
Pyridinium Oximes with Ortho-Positioned Chlorine Moiety Exhibit Improved Physicochemical Properties and Efficient Reactivation of Human Acetylcholinesterase Inhibited by Several Nerve Agents
. 61:10753-10766.
2018
Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats
. 60:10092-10104.
2017
Selective Inhibition of Escherichia coli RNA and DNA Topoisomerase I by Hoechst 33258 Derived Mono- and Bisbenzimidazoles
. 60:4904-4922.
2017
Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa
1
-Arg-(pI)DPhe-Xaa
4
-NH
2
. 60:4342-4357.
2017
Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120
. 60:3124-3153.
2017
Potent μ-Opioid Receptor Agonists from Cyclic Peptides Tyr-c[ d -Lys-Xxx-Tyr-Gly]: Synthesis, Biological, and Structural Evaluation
. 59:1239-1245.
2016
Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity
. 58:6909-6927.
2015
SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes
. 58:5808-5824.
2015
Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at mu (MOR), delta (DOR), and kappa (KOR) Opioid Receptors
. 58:4905-4917.
2015
Combinatorial Libraries As a Tool for the Discovery of Novel, Broad-Spectrum Antibacterial Agents Targeting the ESKAPE Pathogens
. 58:3340-3355.
2015
Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screening
. 58:2036-2041.
2015
Synthesis, Structure-Activity Relationship Studies, and Antibacterial Evaluation of 4-Chromanones and Chalcones, as Well as Olympicin A and Derivatives
. 57:8398-8420.
2014
Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes
. 57:6197-6209.
2014
Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R Human Melanocortin-4 Polymorphic Receptors (hMC4Rs)
. 57:4615-4628.
2014
Discovery of a potent and selective α3β4 nicotinic acetylcholine receptor antagonist from an α-conotoxin synthetic combinatorial library
. 57:3511-3521.
2014
Novel pyrrolidine diketopiperazines selectively inhibit melanoma cells via induction of late-onset apoptosis
. 57:1599-1608.
2014
Synthesis and Cytostatic Evaluation of 4-N-Alkanoyl and 4-N-Alkyl Gemcitabine Analogues
. 57:191-203.
2014
Scaffold Ranking and Positional Scanning Utilized in the Discovery of nAChR-Selective Compounds Suitable for Optimization Studies
. 56:10103-10117.
2013
The multi-leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells
. 55:10501-10511.
2012
Synthesis, Biological Evaluation, X-ray Structure, and Pharmacokinetics of Aminopyrimidine c-jun-N-terminal Kinase (JNK) Inhibitors
. 53:419-431.
2010
Directed discovery of agents targeting the met tyrosine kinase domain by virtual screening
. 52:943-951.
2009
Selectivity and mechanism of action of a growth factor receptor-bound protein 2 Src homology 2 domain binding antagonist
. 51:7459-7468.
2008
Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: Discovery of potent and selective hMC5R receptor antagonists
. 51:2701-2707.
2008
Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors.
. 51:2600-2605.
2008
Design of a potent reactivator of tabun-inhibited acetyleholinesterase-synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203)
. 50:5514-5518.
2007
Antitrypanosomal activity of 5 '-deoxy-5 '-(iodomethylene)adenosine and related 6-N-cyclopropyladenosine analogues
. 49:2096-2102.
2006
Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities
. 49:1946-1952.
2006
Are L-adenosine and its derivatives substrates for S-adenosyl-L-homocysteine hydrolase?
. 48:3649-3653.
2005
Stereoselective synthesis of sugar-modified enyne analogues of adenosine and uridine. Interaction with S-adenosyl-L-homocysteine hydrolase and antiviral and cytotoxic effects
. 47:5251-5257.
2004
Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones
. 47:4032-4040.
2004
Sugar-modified conjugated diene analogues of adenosine and uridine: Synthesis, interaction with S-adenosyl-L-homocysteine hydrolase, and antiviral and cytostatic effects
. 45:2651-2658.
2002
Doubly homologated dihalovinyl and acetylene analogues of adenosine: Synthesis, interaction with S-adenosyl-L-homocysteine hydrolase, and antiviral and cytostatic effects
. 43:1180-1186.
2000
Inactivation of
S
-adenosyl-L-homocysteine hydrolase and antiviral activity with 5′,5′,6′,6′-tetradehydro-6′-deoxy-6′-halohomoadenosine analogues (4′-haloacetylene analogues derived from adenosine)
. 41:3857-3864.
1998
Discovery of type II (covalent) inactivation of S-adenosyl-L-homocysteine hydrolase involving its "hydrolytic activity": Synthesis and evaluation of dihalohomovinyl nucleoside analogues derived from adenosine
. 41:3078-3083.
1998
Anticancer and antiviral effects and inactivation of S-adenosyl-L-homocysteine hydrolase with 5'-carboxaldehydes and oximes synthesized from adenosine and sugar-modified analogues
. 40:1608-1618.
1997
Structure-based design of a new bisintercalating anthracycline antibiotic
. 40:261-266.
1997
Inactivation of S-adenosyl-L-homocysteine hydrolase by amide and ester derivatives of adenosine-5'-carboxylic acid
. 39:4162-4166.
1996
NUCLEIC-ACID RELATED-COMPOUNDS .84. SYNTHESIS OF 6'-(E AND Z)-HALOHOMOVINYL DERIVATIVES OF ADENOSINE, INACTIVATION OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE, AND CORRELATION OF ANTICANCER AND ANTIVIRAL POTENCIES WITH ENZYME-INHIBITION
. 37:3579-3587.
1994
POLYACRYLAMIDES BEARING PENDANT ALPHA-SIALOSIDE GROUPS STRONGLY INHIBIT AGGLUTINATION OF ERYTHROCYTES BY INFLUENZA-A VIRUS - MULTIVALENCY AND STERIC STABILIZATION OF PARTICULATE BIOLOGICAL-SYSTEMS
. 37:3419-3433.
1994
ADENOSINE-5'-CARBOXALDEHYDE - A POTENT INHIBITOR OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE
. 36:883-887.
1993
Synthesis of Pure p-Chlorophenyl-L-alanine form L-Phenylalanine
. 17:556-558.
1974
APPLICATION OF SEQUENTIAL SIMPLEX METHOD IN DESIGNING DRUG ANALOGS
. 17:799-804.
1974
Erratum: Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High Throughput 'Unbiased' Screening Campaign (J. Med. Chem. (2021) 64:9 (5577−5592) DOI: 10.1021/acs.jmedchem.0c02041)
2023
Identification of the 4-Position of 3-Alkynyl and 3-Heteroaromatic Substituted Pyridine Methanamines as a Key Modification Site Eliciting Increased Potency and Enhanced Selectivity for Cytochrome P-450 2A6 Inhibition.
2018
Correction to Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
2017
Synthesis, Biological Evaluation, X-ray Structure, and Pharmacokinetics of Aminopyrimidine c-jun-N-terminal Kinase (JNK) Inhibitors (vol 53, pg 419, 2010)
2010
Mixture-based synthetic combinatorial libraries
1999
Research
category
CHEMISTRY, MEDICINAL
Category
Identifiers
International Standard Serial Number (ISSN)
0022-2623
Electronic International Standard Serial Number (EISSN)
1520-4804
Other
journal abbreviation
J MED CHEM
